Finance PhD: Move Your Money Before April 30th
The clock just starting ticking on the biggest financial event in 20 years. The next few weeks could decide your wealth in 2021.
See what you should do now

YTEN Insider Trading (Yield10 Bioscience)

Insider Ownership Percentage: 1.90%
Insider Buying (Last 12 Months): $1,242,150.00
Insider Selling (Last 12 Months): $0.00

Yield10 Bioscience Insider Trading History Chart

Yield10 Bioscience Share Price & Price History

▼ -0.57 (-4.77%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video)
"Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project…

What happens next will shock you…"
Click here to see what happened.

Yield10 Bioscience Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/3/2021Jack W SchulerMajor ShareholderBuy101,400$12.25$1,242,150.00  
10/1/2019Oliver P PeoplesCEOBuy9,178$0.56$5,139.6866,806  
9/3/2019Oliver P PeoplesCEOBuy10,000$0.82$8,200.0057,628  
8/1/2019Oliver P PeoplesCEOBuy10,000$0.92$9,200.0047,628  
7/5/2019Oliver P PeoplesCEOBuy10,000$0.88$8,800.0037,628  
3/14/2019Jack W SchulerMajor ShareholderBuy552,427$1.21$668,436.67  
See Full Table

SEC Filings (Institutional Ownership Changes) for Yield10 Bioscience (NASDAQ:YTEN)

6.08% of Yield10 Bioscience stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Yield10 Bioscience Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/11/2021Cannell Peter B & Co. Inc.144,625$0.84M0.0%+55.3%3.141%
2/10/2021Renaissance Technologies LLC42,400$0.25M0.0%-24.2%0.921%
11/16/2020Worth Venture Partners LLC39,524$0.31M0.3%N/A1.185%
11/12/2020Cannell Peter B & Co. Inc.93,125$0.72M0.0%+75.3%2.793%
8/7/2020Virtu Financial LLC10,246$64K0.0%N/A0.520%
5/5/2020Cannell Peter B & Co. Inc.53,125$0.20M0.0%N/A2.763%
5/1/2020BlackRock Inc.37,699$0.14M0.0%-97.5%1.960%
2/13/2020Renaissance Technologies LLC582,818$100K0.0%+24.1%185.611%
2/4/2020Virtu Financial LLC330,426$57K0.0%N/A106.589%
8/12/2019Renaissance Technologies LLC478,176$0.46M0.0%+9.5%3.827%
8/13/2018Renaissance Technologies LLC383,376$0.54M0.0%+13.1%3.838%
2/15/2018Sabby Management LLC215,250$0.38M0.0%N/A2.509%
2/15/2018Anson Funds Management LP156,482$0.28M0.2%N/A1.824%
2/13/2018Renaissance Technologies LLC79,576$0.14M0.0%+288.6%0.927%
11/9/2017GMT Capital Corp33,559$0.11M0.0%N/A0.970%
8/9/2017Cannell Peter B & Co. Inc.72,954$0.38M0.0%-90.5%2.561%
8/8/2017Birchview Capital LP226,317$1.05M0.6%-90.0%7.944%
Data available starting January 2016

See Full Table
Yield10 Bioscience logo
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the United States and Canada. The company, through its Trait Factory, is involved in developing high value seed traits for the agriculture and food industries. It also has an oilseed development center in Saskatchewan, Canada. Yield10 Bioscience, Inc. has research agreements with Bayer AG to develop traits in soybean; Forage Genetics International, LLC to develop traits in forage sorghum; J. R. Simplot Company to develop novel traits in potato; and GDM Seeds Inc. to evaluate yield traits in soybeans. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.
Read More

Today's Range

Now: $11.38

50 Day Range

MA: $14.40

52 Week Range

Now: $11.38


25,171 shs

Average Volume

252,237 shs

Market Capitalization

$55.36 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Yield10 Bioscience?

Yield10 Bioscience's top insider investors include:
  1. Oliver P Peoples (CEO)
  2. Jack W Schuler (Major Shareholder)
Millennial Uses Obscure 18-Digit Code to Beat Wall Street
Andrew Keene was "down and out"... until he found an obscure 18-digit "code" that let him see when hedge funds were making incredibly lucrative trades. He realized he could follow along - and take a slice of the profit. He's now a multi-millionaire.
And you can see how his strategy works here.